{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:47:43Z","timestamp":1791848863086,"version":"4.3.4"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41575-021-00527-0","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T12:03:07Z","timestamp":1635768187000},"page":"45-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan Pablo","family":"Arab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhal","family":"Izzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1119-7799","authenticated-orcid":false,"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-573X","authenticated-orcid":false,"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"527_CR1","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Understanding alcohol Use disorder. NIAAA https:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/alcohol-use-disorders (2021)."},{"key":"527_CR2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. & American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5 5th edn (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"527_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","volume":"74","author":"BF Grant","year":"2017","unstructured":"Grant, B. F. et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 74, 911\u2013923 (2017).","journal-title":"JAMA Psychiatry"},{"key":"527_CR4","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.29887","volume":"68","author":"JL Mellinger","year":"2018","unstructured":"Mellinger, J. L. et al. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology 68, 872\u2013882 (2018).","journal-title":"Hepatology"},{"key":"527_CR5","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/S2468-2667(18)30230-5","volume":"4","author":"RF Simpson","year":"2019","unstructured":"Simpson, R. F. et al. Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study. Lancet Public Health 4, e41\u2013e48 (2019).","journal-title":"Lancet Public Health"},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14309\/ajg.0000000000000442","volume":"115","author":"AM Moon","year":"2020","unstructured":"Moon, A. M., Yang, J. Y., Barritt, A. S. T., Bataller, R. & Peery, A. F. Rising mortality from alcohol-associated liver disease in the United States in the 21st century. Am. J. Gastroenterol. 115, 79\u201387 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"527_CR7","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s10620-019-5471-7","volume":"64","author":"AST Barritt","year":"2019","unstructured":"Barritt, A. S. T., Jiang, Y., Schmidt, M., Hayashi, P. H. & Bataller, R. Charges for alcoholic cirrhosis exceed all other etiologies of cirrhosis combined: a national and state inpatient survey analysis. Dig. Dis. Sci. 64, 1460\u20131469 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"527_CR8","doi-asserted-by":"publisher","first-page":"k2817","DOI":"10.1136\/bmj.k2817","volume":"362","author":"EB Tapper","year":"2018","unstructured":"Tapper, E. B. & Parikh, N. D. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ 362, k2817 (2018).","journal-title":"BMJ"},{"key":"527_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","volume":"179","author":"BP Lee","year":"2019","unstructured":"Lee, B. P., Vittinghoff, E., Dodge, J. L., Cullaro, G. & Terrault, N. A. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern. Med. 179, 340\u2013348 (2019).","journal-title":"JAMA Intern. Med."},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/lt.25647","volume":"26","author":"D Erard-Poinsot","year":"2020","unstructured":"Erard-Poinsot, D. et al. Natural history of recurrent alcohol-related cirrhosis after liver transplantation: fast and furious. Liver Transpl. 26, 25\u201333 (2020).","journal-title":"Liver Transpl."},{"key":"527_CR11","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/hep.31042","volume":"71","author":"S Rogal","year":"2020","unstructured":"Rogal, S. et al. Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis. Hepatology 71, 2080\u20132092 (2020).","journal-title":"Hepatology"},{"key":"527_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.15288\/jsa.2003.64.858","volume":"64","author":"LC Sobell","year":"2003","unstructured":"Sobell, L. C. et al. Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems. J. Stud. Alcohol. 64, 858\u2013861 (2003).","journal-title":"J. Stud. Alcohol."},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R. & Grant, M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II. Addiction 88, 791\u2013804 (1993).","journal-title":"Addiction"},{"key":"527_CR14","doi-asserted-by":"publisher","first-page":"E253","DOI":"10.1111\/j.1530-0277.2012.01898.x","volume":"37","author":"JA Johnson","year":"2013","unstructured":"Johnson, J. A., Lee, A., Vinson, D. & Seale, J. P. Use of AUDIT-based measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study. Alcohol. Clin. Exp. Res. 37, E253\u2013E259 (2013).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR15","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","volume":"31","author":"KA Bradley","year":"2007","unstructured":"Bradley, K. A. et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol. Clin. Exp. Res. 31, 1208\u20131217 (2007).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR16","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D. & Bradley, K. A. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch. Intern. Med. 158, 1789\u20131795 (1998).","journal-title":"Arch. Intern. Med."},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archinte.163.7.821","volume":"163","author":"KA Bradley","year":"2003","unstructured":"Bradley, K. A. et al. Two brief alcohol-screening tests from the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch. Intern. Med. 163, 821\u2013829 (2003).","journal-title":"Arch. Intern. Med."},{"key":"527_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1940-0640-9-2","volume":"9","author":"KE Delaney","year":"2014","unstructured":"Delaney, K. E. et al. Inconsistencies between alcohol screening results based on AUDIT-C scores and reported drinking on the AUDIT-C questions: prevalence in two US national samples. Addict. Sci. Clin. Pract. 9, 2 (2014).","journal-title":"Addict. Sci. Clin. Pract."},{"key":"527_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drugalcdep.2016.05.030","volume":"165","author":"PC Kumar","year":"2016","unstructured":"Kumar, P. C. et al. Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients. Drug Alcohol Depend. 165, 38\u201344 (2016).","journal-title":"Drug Alcohol Depend."},{"key":"527_CR20","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","volume":"71","author":"R Parker","year":"2019","unstructured":"Parker, R. et al. Natural history of histologically proven alcohol-related liver disease: a systematic review. J. Hepatol. 71, 586\u2013593 (2019).","journal-title":"J. Hepatol."},{"key":"527_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/S0140-6736(79)92831-9","volume":"2","author":"H Orrego","year":"1979","unstructured":"Orrego, H., Blake, J. E., Blendis, L. M., Kapur, B. M. & Israel, Y. Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 2, 1354\u20131356 (1979).","journal-title":"Lancet"},{"key":"527_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrgastro.2013.247","volume":"11","author":"MR Lucey","year":"2014","unstructured":"Lucey, M. R. Liver transplantation for alcoholic liver disease. Nat. Rev. Gastroenterol. Hepatol. 11, 300\u2013307 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"527_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.alcohol.2019.07.005","volume":"83","author":"JA King","year":"2020","unstructured":"King, J. A. et al. Chronic alcohol-induced liver injury correlates with memory deficits: role for neuroinflammation. Alcohol 83, 75\u201381 (2020).","journal-title":"Alcohol"},{"key":"527_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/acer.13353","volume":"41","author":"MF Fleming","year":"2017","unstructured":"Fleming, M. F. et al. Phosphatidylethanol detects moderate-to-heavy alcohol use in liver transplant recipients. Alcohol. Clin. Exp. Res. 41, 857\u2013862 (2017).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/lt.23596","volume":"19","author":"JP Allen","year":"2013","unstructured":"Allen, J. P., Wurst, F. M., Thon, N. & Litten, R. Z. Assessing the drinking status of liver transplant patients with alcoholic liver disease. Liver Transpl. 19, 369\u2013376 (2013).","journal-title":"Liver Transpl."},{"key":"527_CR26","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/hep.24596","volume":"54","author":"K Staufer","year":"2011","unstructured":"Staufer, K. et al. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology 54, 1640\u20131649 (2011).","journal-title":"Hepatology"},{"key":"527_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/cld.756","volume":"12","author":"BP Lee","year":"2018","unstructured":"Lee, B. P. & Terrault, N. A. Return to alcohol use after liver transplant: patterns and surveillance. Clin. Liver Dis. 12, 160\u2013164 (2018).","journal-title":"Clin. Liver Dis."},{"key":"527_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/acer.14512","volume":"45","author":"J Arnts","year":"2021","unstructured":"Arnts, J. et al. Systematic review: diagnostic accuracy of biomarkers of alcohol use in patients with liver disease. Alcohol. Clin. Exp. Res. 45, 25\u201337 (2021).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR29","doi-asserted-by":"publisher","first-page":"e0190823","DOI":"10.1371\/journal.pone.0190823","volume":"13","author":"A Marot","year":"2018","unstructured":"Marot, A., Dubois, M., Trepo, E., Moreno, C. & Deltenre, P. Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis. PLoS ONE 13, e0190823 (2018).","journal-title":"PLoS ONE"},{"key":"527_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2018.11.007","volume":"70","author":"GY Im","year":"2019","unstructured":"Im, G. Y., Cameron, A. M. & Lucey, M. R. Liver transplantation for alcoholic hepatitis. J. Hepatol. 70, 328\u2013334 (2019).","journal-title":"J. Hepatol."},{"key":"527_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/lt.500030311","volume":"3","author":"RK Fuller","year":"1997","unstructured":"Fuller, R. K. Definition and diagnosis of relapse to drinking. Liver Transpl. Surg. 3, 258\u2013262 (1997).","journal-title":"Liver Transpl. Surg."},{"key":"527_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/lt.20934","volume":"13","author":"R Pfitzmann","year":"2007","unstructured":"Pfitzmann, R. et al. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. 13, 197\u2013205 (2007).","journal-title":"Liver Transpl."},{"key":"527_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/archpsyc.1996.01830030065010","volume":"53","author":"GE Vaillant","year":"1996","unstructured":"Vaillant, G. E. A long-term follow-up of male alcohol abuse. Arch. Gen. Psychiatry 53, 243\u2013249 (1996).","journal-title":"Arch. Gen. Psychiatry"},{"key":"527_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","volume":"150","author":"DW Crabb","year":"2016","unstructured":"Crabb, D. W. et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology 150, 785\u2013790 (2016).","journal-title":"Gastroenterology"},{"key":"527_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/qjmed\/93.1.35","volume":"93","author":"J Fernandez-Sola","year":"2000","unstructured":"Fernandez-Sola, J. et al. Low-dose ethanol consumption allows strength recovery in chronic alcoholic myopathy. QJM 93, 35\u201340 (2000).","journal-title":"QJM"},{"key":"527_CR36","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.29338","volume":"66","author":"J Altamirano","year":"2017","unstructured":"Altamirano, J. et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology 66, 1842\u20131853 (2017).","journal-title":"Hepatology"},{"key":"527_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb, D. W., Im, G. Y., Szabo, G., Mellinger, J. L. & Lucey, M. R. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 71, 306\u2013333 (2020).","journal-title":"Hepatology"},{"key":"527_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","volume":"69","author":"European Association for the Study of the Liver.","year":"2018","unstructured":"European Association for the Study of the Liver.EASL clinical practice guidelines: management of alcohol-related liver disease. J. Hepatol. 69, 154\u2013181 (2018).","journal-title":"J. Hepatol."},{"key":"527_CR39","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.aohep.2019.04.005","volume":"18","author":"JP Arab","year":"2019","unstructured":"Arab, J. P. et al. Alcohol-related liver disease: clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann. Hepatol. 18, 518\u2013535 (2019).","journal-title":"Ann. Hepatol."},{"key":"527_CR40","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1111\/ajt.15569","volume":"19","author":"HE Schlagintweit","year":"2019","unstructured":"Schlagintweit, H. E., Lynch, M. J. & Hendershot, C. S. A review of behavioral alcohol interventions for transplant candidates and recipients with alcohol-related liver disease. Am. J. Transpl. 19, 2678\u20132685 (2019).","journal-title":"Am. J. Transpl."},{"key":"527_CR41","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/hep.26972","volume":"59","author":"P Martin","year":"2014","unstructured":"Martin, P., DiMartini, A., Feng, S., Brown, R. Jr. & Fallon, M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 59, 1144\u20131165 (2014).","journal-title":"Hepatology"},{"key":"527_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(10)60487-4","volume":"376","author":"DL Shawcross","year":"2010","unstructured":"Shawcross, D. L. & O\u2019Grady, J. G. The 6-month abstinence rule in liver transplantation. Lancet 376, 216\u2013217 (2010).","journal-title":"Lancet"},{"key":"527_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/lt.25681","volume":"26","author":"SK Asrani","year":"2020","unstructured":"Asrani, S. K. et al. Meeting report: the Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transpl. 26, 127\u2013140 (2020).","journal-title":"Liver Transpl."},{"key":"527_CR44","first-page":"1","volume":"5","author":"RC Wackernah","year":"2014","unstructured":"Wackernah, R. C., Minnick, M. J. & Clapp, P. Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment. Subst. Abus. Rehabil. 5, 1\u201312 (2014).","journal-title":"Subst. Abus. Rehabil."},{"key":"527_CR45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/jlts.2000.19027","volume":"6","author":"TP Beresford","year":"2000","unstructured":"Beresford, T. P. & Everson, G. T. Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse\u2013but where are the data? Liver Transpl. 6, 777\u2013778 (2000).","journal-title":"Liver Transpl."},{"key":"527_CR46","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2468-1253(19)30451-0","volume":"5","author":"P Mathurin","year":"2020","unstructured":"Mathurin, P. & Lucey, M. R. Liver transplantation in patients with alcohol-related liver disease: current status and future directions. Lancet Gastroenterol. Hepatol. 5, 507\u2013514 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"527_CR47","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","volume":"365","author":"P Mathurin","year":"2011","unstructured":"Mathurin, P. et al. Early liver transplantation for severe alcoholic hepatitis. N. Engl. J. Med. 365, 1790\u20131800 (2011).","journal-title":"N. Engl. J. Med."},{"key":"527_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/lt.20688","volume":"12","author":"A DiMartini","year":"2006","unstructured":"DiMartini, A. et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl. 12, 813\u2013820 (2006).","journal-title":"Liver Transpl."},{"key":"527_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/lt.21278","volume":"14","author":"MA Dew","year":"2008","unstructured":"Dew, M. A. et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 14, 159\u2013172 (2008).","journal-title":"Liver Transpl."},{"key":"527_CR50","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1111\/j.1600-6143.2010.03232.x","volume":"10","author":"A DiMartini","year":"2010","unstructured":"DiMartini, A. et al. Trajectories of alcohol consumption following liver transplantation. Am. J. Transpl. 10, 2305\u20132312 (2010).","journal-title":"Am. J. Transpl."},{"key":"527_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/alcalc\/agx100","volume":"53","author":"S Rogal","year":"2018","unstructured":"Rogal, S. et al. Post-transplant outcomes of persons receiving a liver graft for alcoholic liver disease. Alcohol Alcohol. 53, 157\u2013165 (2018).","journal-title":"Alcohol Alcohol."},{"key":"527_CR52","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/lt.23747","volume":"19","author":"JR Rodrigue","year":"2013","unstructured":"Rodrigue, J. R., Hanto, D. W. & Curry, M. P. Substance abuse treatment and its association with relapse to alcohol use after liver transplantation. Liver Transpl. 19, 1387\u20131395 (2013).","journal-title":"Liver Transpl."},{"key":"527_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/00365520410009591","volume":"40","author":"E Bjornsson","year":"2005","unstructured":"Bjornsson, E. et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand. J. Gastroenterol. 40, 206\u2013216 (2005).","journal-title":"Scand. J. Gastroenterol."},{"key":"527_CR54","first-page":"817","volume":"68","author":"J Arab","year":"2018","unstructured":"Arab, J., Schneekloth, T., Niazi, S. & Simonetto, D. Predictors of alcohol relapse after transplant for alcoholic liver disease. Hepatology 68, 817\u2013818A (2018).","journal-title":"Hepatology"},{"key":"527_CR55","doi-asserted-by":"publisher","first-page":"771","DOI":"10.4254\/wjh.v9.i17.771","volume":"9","author":"J Lim","year":"2017","unstructured":"Lim, J., Curry, M. P. & Sundaram, V. Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J. Hepatol. 9, 771\u2013780 (2017).","journal-title":"World J. Hepatol."},{"key":"527_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12876-019-1050-9","volume":"19","author":"L Chuncharunee","year":"2019","unstructured":"Chuncharunee, L., Yamashiki, N., Thakkinstian, A. & Sobhonslidsuk, A. Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis. BMC Gastroenterol. 19, 150 (2019).","journal-title":"BMC Gastroenterol."},{"key":"527_CR57","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/hep.30478","volume":"69","author":"BP Lee","year":"2019","unstructured":"Lee, B. P. et al. Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score. Hepatology 69, 1477\u20131487 (2019).","journal-title":"Hepatology"},{"key":"527_CR58","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/lt.20386","volume":"11","author":"A Cuadrado","year":"2005","unstructured":"Cuadrado, A., Fabrega, E., Casafont, F. & Pons-Romero, F. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. 11, 420\u2013426 (2005).","journal-title":"Liver Transpl."},{"key":"527_CR59","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/lt.24425","volume":"22","author":"D Erard-Poinsot","year":"2016","unstructured":"Erard-Poinsot, D. et al. Severe alcoholic relapse after liver transplantation: what consequences on the graft? A study based on liver biopsies analysis. Liver Transpl. 22, 773\u2013784 (2016).","journal-title":"Liver Transpl."},{"key":"527_CR60","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/alcalc\/agx098","volume":"53","author":"S Kodali","year":"2018","unstructured":"Kodali, S., Kaif, M., Tariq, R. & Singal, A. K. Alcohol relapse after liver transplantation for alcoholic cirrhosis\u2013impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 53, 166\u2013172 (2018).","journal-title":"Alcohol Alcohol."},{"key":"527_CR61","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/hep.29240","volume":"66","author":"A Louvet","year":"2017","unstructured":"Louvet, A. et al. Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study. Hepatology 66, 1464\u20131473 (2017).","journal-title":"Hepatology"},{"key":"527_CR62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ajt.14559","volume":"18","author":"WR Kim","year":"2018","unstructured":"Kim, W. R. et al. OPTN\/SRTR 2016 annual data report: liver. Am. J. Transpl. 18, 172\u2013253 (2018).","journal-title":"Am. J. Transpl."},{"key":"527_CR63","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0168-8278(01)00002-2","volume":"34","author":"P Burra","year":"2001","unstructured":"Burra, P. et al. Histological features after liver transplantation in alcoholic cirrhotics. J. Hepatol. 34, 716\u2013722 (2001).","journal-title":"J. Hepatol."},{"key":"527_CR64","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1572-0241.2007.01079.x","volume":"102","author":"J Dumortier","year":"2007","unstructured":"Dumortier, J. et al. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center. Am. J. Gastroenterol. 102, 1032\u20131041 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"527_CR65","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/lt.20086","volume":"10","author":"S Jauhar","year":"2004","unstructured":"Jauhar, S. et al. Analysis of factors that predict alcohol relapse following liver transplantation. Liver Transpl. 10, 408\u2013411 (2004).","journal-title":"Liver Transpl."},{"key":"527_CR66","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ajg.2015.204","volume":"110","author":"J Dumortier","year":"2015","unstructured":"Dumortier, J. et al. Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication. Am. J. Gastroenterol. 110, 1160\u20131166 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"527_CR67","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/lt.23762","volume":"19","author":"JP Rice","year":"2013","unstructured":"Rice, J. P. et al. Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis. Liver Transpl. 19, 1377\u20131386 (2013).","journal-title":"Liver Transpl."},{"key":"527_CR68","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0168-8278(03)00088-6","volume":"38","author":"GP Pageaux","year":"2003","unstructured":"Pageaux, G. P. et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J. Hepatol. 38, 629\u2013634 (2003).","journal-title":"J. Hepatol."},{"key":"527_CR69","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1530-0277.2008.00835.x","volume":"33","author":"GA Kenna","year":"2009","unstructured":"Kenna, G. A. et al. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline. Alcohol. Clin. Exp. Res. 33, 315\u2013323 (2009).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/lt.22198","volume":"17","author":"I Laish","year":"2011","unstructured":"Laish, I. et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 17, 15\u201322 (2011).","journal-title":"Liver Transpl."},{"key":"527_CR71","first-page":"721","volume":"15","author":"JP Arab","year":"2016","unstructured":"Arab, J. P. et al. High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients. Ann. Hepatol. 15, 721\u2013728 (2016).","journal-title":"Ann. Hepatol."},{"key":"527_CR72","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1600-6143.2009.02869.x","volume":"10","author":"P Burra","year":"2010","unstructured":"Burra, P. et al. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am. J. Transpl. 10, 138\u2013148 (2010).","journal-title":"Am. J. Transpl."},{"key":"527_CR73","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/lt.22259","volume":"17","author":"RM Weinrieb","year":"2011","unstructured":"Weinrieb, R. M., Van Horn, D. H., Lynch, K. G. & Lucey, M. R. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl. 17, 539\u2013547 (2011).","journal-title":"Liver Transpl."},{"key":"527_CR74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","volume":"14","author":"A Khan","year":"2016","unstructured":"Khan, A. et al. Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review. Clin. Gastroenterol. Hepatol. 14, 191\u2013202.e4 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"527_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","volume":"175","author":"VI Reus","year":"2018","unstructured":"Reus, V. I. et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am. J. Psychiatry 175, 86\u201390 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"527_CR76","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Clinical and Research Information on Drug-Induced Liver Injury. LiverTox [online] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/ (updated 12 Oct 2021)."},{"key":"527_CR77","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40263-013-0043-4","volume":"27","author":"G Addolorato","year":"2013","unstructured":"Addolorato, G., Mirijello, A., Leggio, L., Ferrulli, A. & Landolfi, R. Management of alcohol dependence in patients with liver disease. CNS Drugs 27, 287\u2013299 (2013).","journal-title":"CNS Drugs"},{"key":"527_CR78","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0168-8278(97)80355-8","volume":"27","author":"M Bertolotti","year":"1997","unstructured":"Bertolotti, M. et al. Effect of liver cirrhosis on the systemic availability of naltrexone in humans. J. Hepatol. 27, 505\u2013511 (1997).","journal-title":"J. Hepatol."},{"key":"527_CR79","unstructured":"UpToDate. Lexicomp\u00ae Drug Interactions. UpToDate https:\/\/www.uptodate.com\/drug-interactions\/?source=responsive_home#di-druglist (2020)."},{"key":"527_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.alcohol.2006.05.003","volume":"38","author":"MH Yen","year":"2006","unstructured":"Yen, M. H., Ko, H. C., Tang, F. I., Lu, R. B. & Hong, J. S. Study of hepatotoxicity of naltrexone in the treatment of alcoholism. Alcohol 38, 117\u2013120 (2006).","journal-title":"Alcohol"},{"key":"527_CR81","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1530-0277.2007.00593.x","volume":"32","author":"MR Lucey","year":"2008","unstructured":"Lucey, M. R., Silverman, B. L., Illeperuma, A. & O\u2019Brien, C. P. Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics. Alcohol. Clin. Exp. Res. 32, 498\u2013504 (2008).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR82","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton, R. F. et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295, 2003\u20132017 (2006).","journal-title":"JAMA"},{"key":"527_CR83","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/pcn.12914","volume":"73","author":"H Miyata","year":"2019","unstructured":"Miyata, H. et al. Nalmefene in alcohol-dependent patients with a high drinking risk: randomized controlled trial. Psychiatry Clin. Neurosci. 73, 697\u2013706 (2019).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"527_CR84","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0269881114527362","volume":"28","author":"W van den Brink","year":"2014","unstructured":"van den Brink, W. et al. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: a 1-year, randomised controlled study. J. Psychopharmacol. 28, 733\u2013744 (2014).","journal-title":"J. Psychopharmacol."},{"key":"527_CR85","unstructured":"European Medicines Agency. Selincro: nalmefene. EMA https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/selincro#:~:text=The%20active%20substance%20in%20Selincro,to%20large%20amounts%20of%20alcohol (2019)."},{"key":"527_CR86","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bcp.12070","volume":"77","author":"NJ Kalk","year":"2014","unstructured":"Kalk, N. J. & Lingford-Hughes, A. R. The clinical pharmacology of acamprosate. Br. J. Clin. Pharmacol. 77, 315\u2013323 (2014).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"527_CR87","first-page":"687","volume":"16","author":"T Delgrange","year":"1992","unstructured":"Delgrange, T., Khater, J., Capron, D., Duron, B. & Capron, J. P. Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis [French]. Gastroenterol. Clin. Biol. 16, 687\u2013691 (1992).","journal-title":"Gastroenterol. Clin. Biol."},{"key":"527_CR88","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0269881103174017","volume":"17","author":"J Chick","year":"2003","unstructured":"Chick, J., Lehert, P., Landron, F. & Plinius Maior, S. Does acamprosate improve reduction of drinking as well as aiding abstinence? J. Psychopharmacol. 17, 397\u2013402 (2003).","journal-title":"J. Psychopharmacol."},{"key":"527_CR89","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","volume":"101","author":"KC Morley","year":"2006","unstructured":"Morley, K. C. et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 101, 1451\u20131462 (2006).","journal-title":"Addiction"},{"key":"527_CR90","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","volume":"311","author":"DE Jonas","year":"2014","unstructured":"Jonas, D. E. et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA 311, 1889\u20131900 (2014).","journal-title":"JAMA"},{"key":"527_CR91","unstructured":"Department of Veterans Affairs, Department of Defense. VA\/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. Health Quality http:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/VADoDSUDCPGProviderSummaryRevised22216.pdf (2015)."},{"key":"527_CR92","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"BA Johnson","year":"2003","unstructured":"Johnson, B. A. et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361, 1677\u20131685 (2003).","journal-title":"Lancet"},{"key":"527_CR93","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","volume":"298","author":"BA Johnson","year":"2007","unstructured":"Johnson, B. A. et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298, 1641\u20131651 (2007).","journal-title":"JAMA"},{"key":"527_CR94","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1176\/appi.ajp.2013.13081014","volume":"171","author":"HR Kranzler","year":"2014","unstructured":"Kranzler, H. R. et al. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am. J. Psychiatry 171, 445\u2013452 (2014).","journal-title":"Am. J. Psychiatry"},{"key":"527_CR95","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S2215-0366(18)30303-1","volume":"5","author":"R Agabio","year":"2018","unstructured":"Agabio, R. et al. Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. Lancet Psychiatry 5, 957\u2013960 (2018).","journal-title":"Lancet Psychiatry"},{"key":"527_CR96","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","volume":"370","author":"G Addolorato","year":"2007","unstructured":"Addolorato, G. et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370, 1915\u20131922 (2007).","journal-title":"Lancet"},{"key":"527_CR97","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1192\/bjp.2018.13","volume":"212","author":"KC Morley","year":"2018","unstructured":"Morley, K. C. et al. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial. Br. J. Psychiatry 212, 362\u2013369 (2018).","journal-title":"Br. J. Psychiatry"},{"key":"527_CR98","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/add.13787","volume":"112","author":"P Hauser","year":"2017","unstructured":"Hauser, P. et al. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial. Addiction 112, 1173\u20131183 (2017).","journal-title":"Addiction"},{"key":"527_CR99","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","volume":"26","author":"EM Beraha","year":"2016","unstructured":"Beraha, E. M. et al. Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial. Eur. Neuropsychopharmacol. 26, 1950\u20131959 (2016).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"527_CR100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jsat.2014.11.007","volume":"52","author":"AM Ponizovsky","year":"2015","unstructured":"Ponizovsky, A. M., Rosca, P., Aronovich, E., Weizman, A. & Grinshpoon, A. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up. J. Subst. Abus. Treat. 52, 24\u201330 (2015).","journal-title":"J. Subst. Abus. Treat."},{"key":"527_CR101","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","volume":"34","author":"JC Garbutt","year":"2010","unstructured":"Garbutt, J. C., Kampov-Polevoy, A. B., Gallop, R., Kalka-Juhl, L. & Flannery, B. A. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol. Clin. Exp. Res. 34, 1849\u20131857 (2010).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR102","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S. & Shah, V. H. ACG clinical guideline: alcoholic liver disease. Am. J. Gastroenterol. 113, 175\u2013194 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"527_CR103","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/15563650.2017.1284330","volume":"55","author":"F Pelissier","year":"2017","unstructured":"Pelissier, F. et al. Self-poisoning with baclofen in alcohol-dependent patients: national reports to French Poison Control Centers, 2008-2013. Clin. Toxicol. 55, 275\u2013284 (2017).","journal-title":"Clin. Toxicol."},{"key":"527_CR104","doi-asserted-by":"publisher","first-page":"e0126870","DOI":"10.1371\/journal.pone.0126870","volume":"10","author":"N Darvishi","year":"2015","unstructured":"Darvishi, N., Farhadi, M., Haghtalab, T. & Poorolajal, J. Alcohol-related risk of suicidal ideation, suicide attempt, and completed suicide: a meta-analysis. PLoS ONE 10, e0126870 (2015).","journal-title":"PLoS ONE"},{"key":"527_CR105","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1523\/JNEUROSCI.0575-08.2008","volume":"28","author":"M Roberto","year":"2008","unstructured":"Roberto, M. et al. Cellular and behavioral interactions of gabapentin with alcohol dependence. J. Neurosci. 28, 5762\u20135771 (2008).","journal-title":"J. Neurosci."},{"key":"527_CR106","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","volume":"174","author":"BJ Mason","year":"2014","unstructured":"Mason, B. J. et al. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern. Med. 174, 70\u201377 (2014).","journal-title":"JAMA Intern. Med."},{"key":"527_CR107","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0920-1211(94)90034-5","volume":"18","author":"The US Gabapentin Study Group.","year":"1994","unstructured":"The US Gabapentin Study Group.The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. Epilepsy Res. 18, 67\u201373 (1994).","journal-title":"Epilepsy Res."},{"key":"527_CR108","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1369-1600.2008.00133.x","volume":"14","author":"BJ Mason","year":"2009","unstructured":"Mason, B. J., Light, J. M., Williams, L. D. & Drobes, D. J. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict. Biol. 14, 73\u201383 (2009).","journal-title":"Addict. Biol."},{"key":"527_CR109","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","volume":"180","author":"RF Anton","year":"2020","unstructured":"Anton, R. F. et al. Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial. JAMA Intern. Med. 180, 728\u2013736 (2020).","journal-title":"JAMA Intern. Med."},{"key":"527_CR110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/acer.13917","volume":"43","author":"DE Falk","year":"2019","unstructured":"Falk, D. E. et al. Gabapentin enacarbil extended-release for alcohol use disorder: a randomized, double-blind, placebo-controlled, multisite trial assessing efficacy and safety. Alcohol. Clin. Exp. Res. 43, 158\u2013169 (2019).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR111","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/187152710790966614","volume":"9","author":"L Leggio","year":"2010","unstructured":"Leggio, L., Garbutt, J. C. & Addolorato, G. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS Neurol. Disord. Drug Targets 9, 33\u201344 (2010).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"527_CR112","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jamapsychiatry.2017.3544","volume":"75","author":"SS O\u2019Malley","year":"2018","unstructured":"O\u2019Malley, S. S. et al. Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: a randomized clinical trial. JAMA Psychiatry 75, 129\u2013138 (2018).","journal-title":"JAMA Psychiatry"},{"key":"527_CR113","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2165\/11537850-000000000-00000","volume":"49","author":"HM Faessel","year":"2010","unstructured":"Faessel, H. M. et al. A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. Clin. Pharmacokinet. 49, 799\u2013816 (2010).","journal-title":"Clin. Pharmacokinet."},{"key":"527_CR114","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17116\/jnevro202012001133","volume":"120","author":"EM Krupitsky","year":"2020","unstructured":"Krupitsky, E. M., Rybakova, K. V., Skurat, E. P., Semenova, N. V. & Neznanov, N. G. A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence. Zh. Nevrol. Psikhiatr Im. S S Korsakova 120, 33\u201343 (2020).","journal-title":"Zh. Nevrol. Psikhiatr Im. S S Korsakova"},{"key":"527_CR115","doi-asserted-by":"publisher","first-page":"eaax4043","DOI":"10.1126\/sciadv.aax4043","volume":"5","author":"K Witkiewitz","year":"2019","unstructured":"Witkiewitz, K., Litten, R. Z. & Leggio, L. Advances in the science and treatment of alcohol use disorder. Sci. Adv. 5, eaax4043 (2019).","journal-title":"Sci. Adv."},{"key":"527_CR116","doi-asserted-by":"publisher","first-page":"e208279","DOI":"10.1001\/jamanetworkopen.2020.8279","volume":"3","author":"LA Ray","year":"2020","unstructured":"Ray, L. A. et al. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Netw. Open 3, e208279 (2020).","journal-title":"JAMA Netw. Open"},{"key":"527_CR117","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","volume":"146","author":"J Altamirano","year":"2014","unstructured":"Altamirano, J. et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 146, 1231\u20131239.e6 (2014).","journal-title":"Gastroenterology"},{"key":"527_CR118","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.psym.2019.12.004","volume":"61","author":"GS Winder","year":"2020","unstructured":"Winder, G. S., Fernandez, A. C., Klevering, K. & Mellinger, J. L. Confronting the crisis of comorbid alcohol use disorder and alcohol-related liver disease with a novel multidisciplinary clinic. Psychosomatics 61, 238\u2013253 (2020).","journal-title":"Psychosomatics"},{"key":"527_CR119","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/hep.31583","volume":"73","author":"SK Asrani","year":"2021","unstructured":"Asrani, S. K., Mellinger, J., Arab, J. P. & Shah, V. H. Reducing the global burden of alcohol-associated liver disease: a blueprint for action. Hepatology 73, 2039\u20132050 (2021).","journal-title":"Hepatology"},{"key":"527_CR120","doi-asserted-by":"publisher","first-page":"108396","DOI":"10.1016\/j.jsat.2021.108396","volume":"130","author":"JL Mellinger","year":"2021","unstructured":"Mellinger, J. L. et al. Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic. J. Subst. Abus. Treat. 130, 108396 (2021).","journal-title":"J. Subst. Abus. Treat."},{"key":"527_CR121","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.transproceed.2018.02.212","volume":"51","author":"P Magistri","year":"2019","unstructured":"Magistri, P. et al. Impact of a multidisciplinary team on alcohol recidivism and survival after liver transplant for alcoholic disease. Transpl. Proc. 51, 187\u2013189 (2019).","journal-title":"Transpl. Proc."},{"key":"527_CR122","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/acer.12117","volume":"37","author":"G Addolorato","year":"2013","unstructured":"Addolorato, G. et al. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol. Clin. Exp. Res. 37, 1601\u20131608 (2013).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR123","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpsychores.2018.11.020","volume":"116","author":"H Lopez-Pelayo","year":"2019","unstructured":"Lopez-Pelayo, H. et al. Treatment retention in a specialized alcohol programme after an episode of alcoholic hepatitis: impact on alcohol relapse. J. Psychosom. Res. 116, 75\u201382 (2019).","journal-title":"J. Psychosom. Res."},{"key":"527_CR124","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/lt.25641","volume":"25","author":"H Donnadieu-Rigole","year":"2019","unstructured":"Donnadieu-Rigole, H. et al. Integration of an addiction team in a liver transplantation center. Liver Transpl. 25, 1611\u20131619 (2019).","journal-title":"Liver Transpl."},{"key":"527_CR125","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.31276","volume":"72","author":"M Serper","year":"2020","unstructured":"Serper, M. et al. Telemedicine in liver disease and beyond: can the COVID-19 crisis lead to action? Hepatology 72, 723\u2013728 (2020).","journal-title":"Hepatology"},{"key":"527_CR126","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1360-0443.2005.01216.x","volume":"100","author":"B Hock","year":"2005","unstructured":"Hock, B. et al. Validity of carbohydrate-deficient transferrin (%CDT), \u03b3-glutamyltransferase (\u03b3-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 100, 1477\u20131486 (2005).","journal-title":"Addiction"},{"key":"527_CR127","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/milmed\/168.5.364","volume":"168","author":"JP Allen","year":"2003","unstructured":"Allen, J. P. Use of biomarkers of heavy drinking in health care practice. Mil. Med. 168, 364\u2013367 (2003).","journal-title":"Mil. Med."},{"key":"527_CR128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-0773.1990.tb00704.x","volume":"66","author":"AW Jones","year":"1990","unstructured":"Jones, A. W., Skagerberg, S., Yonekura, T. & Sato, A. Metabolic interaction between endogenous methanol and exogenous ethanol studied in human volunteers by analysis of breath. Pharmacol. Toxicol. 66, 62\u201365 (1990).","journal-title":"Pharmacol. Toxicol."},{"key":"527_CR129","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/alcalc\/agq003","volume":"45","author":"A Heberlein","year":"2010","unstructured":"Heberlein, A. et al. Methanol levels in saliva\u2013a non-invasive parameter that may be useful in detection of alcohol intoxication. Alcohol Alcohol. 45, 126\u2013127 (2010).","journal-title":"Alcohol Alcohol."},{"key":"527_CR130","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1530-0277.2002.tb02641.x","volume":"26","author":"A Helander","year":"2002","unstructured":"Helander, A. & Eriksson, C. J. Laboratory tests for acute alcohol consumption: results of the WHO\/ISBRA study on state and trait markers of alcohol use and dependence. Alcohol. Clin. Exp. Res. 26, 1070\u20131077 (2002).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR131","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/lt.23468","volume":"18","author":"JM Hempel","year":"2012","unstructured":"Hempel, J. M., Greif-Higer, G., Kaufmann, T. & Beutel, M. E. Detection of alcohol consumption in patients with alcoholic liver cirrhosis during the evaluation process for liver transplantation. Liver Transpl. 18, 1310\u20131315 (2012).","journal-title":"Liver Transpl."},{"key":"527_CR132","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cca.2017.03.018","volume":"467","author":"A Helander","year":"2017","unstructured":"Helander, A. et al. Reprint of standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clin. Chim. Acta 467, 15\u201320 (2017).","journal-title":"Clin. Chim. Acta"},{"key":"527_CR133","first-page":"55","volume":"23","author":"F Bortolotti","year":"2011","unstructured":"Bortolotti, F. & Tagliaro, F. Biomarkers for the identification of alcohol use\/abuse: a critical review. Forensic Sci. Rev. 23, 55\u201372 (2011).","journal-title":"Forensic Sci. Rev."},{"key":"527_CR134","doi-asserted-by":"publisher","first-page":"e0244336","DOI":"10.1371\/journal.pone.0244336","volume":"15","author":"K Iglesias","year":"2020","unstructured":"Iglesias, K. et al. Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men. PLoS ONE 15, e0244336 (2020).","journal-title":"PLoS ONE"},{"key":"527_CR135","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/alcalc\/agz015","volume":"54","author":"R Paul","year":"2019","unstructured":"Paul, R. et al. Ethyl glucuronide as a long-term alcohol biomarker in fingernail and hair. Matrix comparison and evaluation of gender bias. Alcohol Alcohol. 54, 402\u2013407 (2019).","journal-title":"Alcohol Alcohol."},{"key":"527_CR136","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/acer.13558","volume":"42","author":"VL Nguyen","year":"2018","unstructured":"Nguyen, V. L., Haber, P. S. & Seth, D. Applications and challenges for the use of phosphatidylethanol testing in liver disease patients (mini review). Alcohol. Clin. Exp. Res. 42, 238\u2013243 (2018).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"527_CR137","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.drugalcdep.2017.05.031","volume":"178","author":"SM Alessi","year":"2017","unstructured":"Alessi, S. M., Barnett, N. P. & Petry, N. M. Experiences with SCRAMx alcohol monitoring technology in 100 alcohol treatment outpatients. Drug Alcohol. Depend. 178, 417\u2013424 (2017).","journal-title":"Drug Alcohol. Depend."},{"key":"527_CR138","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/alcalc\/agt134","volume":"48","author":"EM Gurvich","year":"2013","unstructured":"Gurvich, E. M., Kenna, G. A. & Leggio, L. Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials. Alcohol Alcohol. 48, 712\u2013719 (2013).","journal-title":"Alcohol Alcohol."},{"key":"527_CR139","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.alcohol.2019.07.002","volume":"81","author":"MK Jung","year":"2019","unstructured":"Jung, M. K. Introduction to a special issue on wearable alcohol biosensors: development, use, and state of the field. Alcohol 81, 79\u201381 (2019).","journal-title":"Alcohol"},{"key":"527_CR140","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nrgastro.2012.137","volume":"9","author":"M Loiselle","year":"2012","unstructured":"Loiselle, M. & Bataller, R. Detecting alcohol intake in patients with ALD. Nat. Rev. Gastroenterol. Hepatol. 9, 432\u2013434 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00527-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:20:39Z","timestamp":1733959239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-021-00527-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1038\/s41575-021-00527-0","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"21 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}